Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alick C Stephens

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Current Opinion in Molecular Therapeutics|May 30, 2003
Web alert. Oligonucleotide, antibody and peptide therapeuticsAlick C Stephens
Current Opinion in Molecular Therapeutics|March 12, 2004
Web alert. Molecular, viral and cell-based vaccines for disease prevention and therapyAlick C Stephens
Current Opinion in Molecular Therapeutics|November 13, 2004
Technology evaluation: AVI-4126, AVI BioPharmaAlick C Stephens
Current Opinion in Molecular Therapeutics|August 17, 2010
Gene transfer and cell-based therapiesAlick C Stephens
Current Opinion in Molecular Therapeutics|September 30, 2003
Web alert. Gene transfer and cell-based therapiesAlick C Stephens
Current Opinion in Molecular Therapeutics|May 30, 2003
Antisense oligonucleotide therapy in cancerAlick C Stephens, Rodney P A Rivers
Methods in Molecular Biology (Clifton, N.J.)|June 10, 2019
The Use of Dual-Cell-Tracker Dye Staining for the Identification and Characterization of Peanut-Specific T-Cell SubsetsCecilia Dunsterville, Alick C Stephens, Gideon Lack, et al.
Thrombosis Research|October 9, 2007
Suppression of HUVEC tissue factor synthesis by antisense oligodeoxynucleotideAlick C Stephens, Nancy F Ranlall, Rodney P A Rivers
Critical Care Medicine|August 13, 2005
Changes in the interleukin-6/soluble interleukin-6 receptor axis in meningococcal septic shockNazima Pathan, E John Williams, E Emanuelle Oragui, et al.
The Journal of Allergy and Clinical Immunology|April 24, 2013
Distribution of peanut protein in the home environmentHelen A Brough, Kerry Makinson, Martin Penagos, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Current Opinion in Molecular Therapeutics|May 30, 2003
Web alert. Oligonucleotide, antibody and peptide therapeuticsAlick C Stephens
Current Opinion in Molecular Therapeutics|March 12, 2004
Web alert. Molecular, viral and cell-based vaccines for disease prevention and therapyAlick C Stephens
Current Opinion in Molecular Therapeutics|November 13, 2004
Technology evaluation: AVI-4126, AVI BioPharmaAlick C Stephens
Current Opinion in Molecular Therapeutics|August 17, 2010
Gene transfer and cell-based therapiesAlick C Stephens
Current Opinion in Molecular Therapeutics|September 30, 2003
Web alert. Gene transfer and cell-based therapiesAlick C Stephens
Current Opinion in Molecular Therapeutics|May 30, 2003
Antisense oligonucleotide therapy in cancerAlick C Stephens, Rodney P A Rivers
Methods in Molecular Biology (Clifton, N.J.)|June 10, 2019
The Use of Dual-Cell-Tracker Dye Staining for the Identification and Characterization of Peanut-Specific T-Cell SubsetsCecilia Dunsterville, Alick C Stephens, Gideon Lack, et al.
Thrombosis Research|October 9, 2007
Suppression of HUVEC tissue factor synthesis by antisense oligodeoxynucleotideAlick C Stephens, Nancy F Ranlall, Rodney P A Rivers
Critical Care Medicine|August 13, 2005
Changes in the interleukin-6/soluble interleukin-6 receptor axis in meningococcal septic shockNazima Pathan, E John Williams, E Emanuelle Oragui, et al.
The Journal of Allergy and Clinical Immunology|April 24, 2013
Distribution of peanut protein in the home environmentHelen A Brough, Kerry Makinson, Martin Penagos, et al.
Pageof 2